WhaleCreep

Which hedge funds own INMB? INMUNE BIO INC, Q2 2026 13F holders

9 tracked hedge funds disclosed a position in INMB (INMUNE BIO INC) in their Q2 2026 13F filings, worth $1.8m in total. The largest holder by portfolio weight is Scientech Research LLC at 0.0% of its book. 6 opened a new position this quarter: Scientech Research LLC, Gsa Capital Partners LLP, Millennium Management LLC, Citadel Advisors LLC.

9
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
6
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
0
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$678k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$0
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$1.8m
Combined value
Sum of the holders' reported positions in the security.
0.7%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.

Holders, Q2 2026

9 rows
Scientech Research LLC Hedge fund0.01%$17.1k10,483–new
Gsa Capital Partners LLP Hedge fund0.01%$134k81,991–new
AQR Capital Management LLC Hedge fund0.0%$1.1m662,218+145%added
Millennium Management LLC Hedge fund0.0%$260k159,559–new
Citadel Advisors LLC Hedge fund0.0%$173k106,231–new
Qube Research & Technologies Ltd Hedge fund0.0%$66.5k40,773–new
Renaissance Technologies LLC Hedge fund0.0%$48.4k29,700+75%added
Squarepoint Ops LLC Hedge fund0.0%$26.1k16,043+0.1%held
Point72 Asset Management, L.P. Hedge fund0.0%$27.0k16,577–new